Board of Directors

Chair of Valuation
Member of the Nominating Governance and Compensation Committee

In addition to serving as the company’s CEO, Robert Chew is an internationally recognized compliance consultant in the areas of risk-based qualification, validation, ASTM E2500 (key author of that standard), and ICH-Q9, Quality Risk Management. Mr. Chew has provided quality risk management consulting to some of the largest pharmaceutical and biotechnology companies in the world. Over the past decade, he has spoken at international conferences in the US, Europe, Asia, and South America. He is an official trainer for ISPE’s Commissioning and Qualification Baseline Guide. Mr. Chew is an industry leader in creating value-added approaches to qualification. He was ISPE’s 2008 Member of the Year. He is a member of the Global Pharmaceutical Manufacturing Leadership Forum. He is the chief architect and prospective patent holder for the company’s BioVoke™ GMP Information Management Suite.

Chair of Compensation Committee
Member of the Audit and Valuation Committee

Tom is a Certified Public Accountant (CPA) and has served on the Board of Directors since the inception of the ESOP in January 2008. He also currently serves as the Lead Independent Director for the Board.

He recently retired from the practice of public accounting after a career that spanned 49 years. Immediately prior to his retirement in May 2023, Tom served as the Managing Partner for Sponsel CPA Group an Indianapolis based CPA firm that he started in 2009 and currently employs 40+ team members. His professional experience includes providing advisory services on entrepreneurial startups, mergers and acquisitions, succession planning, organizational structure, and strategic planning. He also holds the ABV designation “Accredited in Business Valuation” and has testified extensively in court proceedings on matters related to business valuations and economic damages.He proved his own entrepreneurial skills in starting his own CPA firm in 2009.

His professional contributions and recognitions include the Indiana CPA Society’s( INCPAS) President’s Award for his distinguished service to the CPA profession and was also the recipient of the INCPAS Outstanding CPA in Public Practice award. He has been involved in a number of community organizations in volunteer leadership roles.

Chair of Technology, Investments, and Acquisitions
Member of the Compensation and Valuation Committee

Mr. Douglas Curry has served on the Commissioning Agents Board of Directors since December 2015. Doug is a serial entrepreneur with a passion for early-stage technology, company formation, developing a strategic vision that leads to growth, and developing markets to commercialize those technologies.

Over the past 25 years, Doug has started and sold technology-based companies. Doug was the Manager of New Venture Projects at an incubator business development affiliated with the University of Chicago and Federal Labs. His efforts led to the creation and funding of several new companies while at the incubator. An adept strategist with a solid combination of business and technical acumen in new products and services across multiple market segments resulting in record growth.

Doug is an active mentor for individuals who are thinking of starting a company that is technology based.

Chair of the Global Risk Committee
Member of the Compensation
Technology, Investment, and Acquisitions Committee

Cyd Brandvein is a global enterprise resilience executive and board director with over 20 years of continuous progressionand achievement in helping global tech and engineering corporations navigate complexity. In her prior executive roles atGoogle/Alphabet and AECOM Inc., Cyd envisioned global strategy and enterprise resilience through innovative ways tosafeguard global operations that were instrumental to protect reputation, operations, and financial performance in serviceand product areas.

As an experienced board member, Cyd has advanced the mission of founding and established company boards as wellas government, advisory, and nonprofit boards, by leveraging expertise in strategic planning, risk management,succession planning, talent development, and regulatory compliance and disclosure. She currently serves as an independent member of CAI’s Board, chairs the Global Risk Committee, and sits on the Compensation Committee and the Technology, Mergers, and Innovation Committee. Previously, she headed the State of California Board of Optometryas President and Vice President, and led 3 committees during 2 terms, which showcased her effective public serviceleadership to navigate various levels of management and departments within the Department of Consumer Affairs and Governor’s office. She also completed 2 terms with the Girl Scouts of Orange County Board, served as Assistant Secretary to the Board of an AECOM founding company, and sat on the Advisory Merger & Integration Advisory,Customer Experience Committee, Branding Strategy Council for America West Airlines during its merger with U.S. Airways Group.

Cyd earned a Bachelor of Arts in Political Science from the University of California, Los Angeles (UCLA), and completed extensive advanced education in corporate board governance and public service leadership. She stays connected to her alma mater by serving on UCLA Alumni Association committees and mentoring the next generation of UCLA’s business leaders and public servants.

Member of the Valuation Committee
Member of the Valuation and Global Risk Committee

Mike invested his career of 30+ years in the pharmaceutical industry. Most of his employment was with a large global pharmaceutical company. Currently, he serves as the president of CAI, an engineering consulting company which primarily serves the pharmaceutical industry.  Mike is a Mechanical Engineer with a Master’s in Business Administration. He has a variety of experiences in engineering, operational leadership, engineering leadership, and large-scale project management in diverse global settings.  Mike has delivered major capital projects in the US, Puerto Rico, China, and Ireland.

He has led very diverse teams in very challenging settings. He has integrated himself successfully into a variety of cultures and locations and has inspired teams to achieve very difficult goals in a wide variety of opportunities.   Mike has experience in a variety of types of pharmaceutical manufacturing operations including dry product manufacturing, aseptic manufacturing, API manufacturing, and delivery device manufacturing. He has led engineering organizations, operational organizations, and large project organizations across these types of manufacturing areas.

Chair of the Audit Committee
Member of the Global Risk Committee and Nom/Gov Committee

Pam Smith has over 30 years of business leadership and experience across Finance, Accounting, Compliance, Governance, M&A and Financial Reporting on a global scale.  Ms. Smith is currently the Founder & CEO of PF Smith Consulting, a results driven consulting firm that provides interim CFO services, solves financial challenges, establishes strategy and improves profitability for clients.

Prior to founding her firm, Ms. Smith served as Senior Vice President of Corporate Financial Planning & Analysis for Estee Lauder Companies and Senior Vice President & CFO for Redbox. She also held leadership positions at Procter & Gamble, Bank of America and Sara Lee.

Ms. Smith presently serves on the boards of the American Pop Corn Company (APCC) and the Florida First Coast YMCA.  She serves as the Evaluation and Compensation Committee Chair at APCC and Treasurer and Finance Committee Chair for the Florida First Coast YMCA. Ms. Smith received her Bachelor of Science degree from the University of Virginia.

Chaz Calitri is the Vice President of Operations for Sterile Injectables US/EU for Pfizer Inc. He is long term active member of the International Society of Pharmaceutical Engineers. Chaz has devoted his entire career to the Pharmaceutical Industry. He has held assignments and leadership positions in areas including Production Operations, Global Engineering, Capital Projects Management, Facilities Management, and Site Engineering.

In 2020 Chaz led the Kalamazoo manufacturing site which enabled, scaled-up and launched Pfizer’s Covid-19 Vaccine. He holds a B.S. degree in Chemical Engineering from Cornell University and an MBA in International Business from Fairleigh Dickinson University. He is a licensed Professional Engineer in New York and New Jersey. Chaz resides in Ventnor City, New Jersey with his two daughters.

Outside of work, Chaz enjoys biking and reading. Recently he has been studying Mindfulness and Meditation.

Dave Sternasty recently retired as the Vice President of Corporate Engineering and Global Health, Safety, and Environment (HSE) for Lilly. He has over 35 years of pharmaceutical operations and engineering experience with Lilly and Aventis Pharmaceuticals, having worked and lived in Cincinnati, Indianapolis, Puerto Rico, and France. Dave played a crucial role in the design, construction, qualification, and operation of fill/finish and API manufacturing sites across various locations.

He recieved a BS degree in Chemical Engineering from the University of Cincinnati. Additionally, Dave serves as a board member for several non-profits, including the Minority Engineering Program of Indianapolis and Purposeful Design. He is also a Fellow for the SMART Manufacturing Grant committee for Conexus in Indiana. Dave and his wife Teresa reside in Indianapolis and have three grown children and one grandson.